LTC Properties Valuation

Is LTC undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

5/6

Valuation Score 5/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of LTC when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: LTC ($38.7) is trading below our estimate of fair value ($59.77)

Significantly Below Fair Value: LTC is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for LTC?

Key metric: As LTC is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for LTC. This is calculated by dividing LTC's market cap by their current earnings.
What is LTC's PE Ratio?
PE Ratio17.4x
EarningsUS$100.53m
Market CapUS$1.74b

Price to Earnings Ratio vs Peers

How does LTC's PE Ratio compare to its peers?

The above table shows the PE ratio for LTC vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average40.6x
SILA Sila Realty Trust
62.1x8.4%US$1.4b
NHI National Health Investors
27.9x10.8%US$3.5b
SBRA Sabra Health Care REIT
44.7x18.8%US$4.4b
STRW Strawberry Fields REIT
27.8x110.2%US$660.0m
LTC LTC Properties
17.4x-4.7%US$1.7b

Price-To-Earnings vs Peers: LTC is good value based on its Price-To-Earnings Ratio (17.4x) compared to the peer average (40.7x).


Price to Earnings Ratio vs Industry

How does LTC's PE Ratio compare vs other companies in the Global Health Care REITs Industry?

1 CompanyPrice / EarningsEstimated GrowthMarket Cap
LTC 17.4xIndustry Avg. 26.5xNo. of Companies5PE020406080100+
1 CompanyEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: LTC is good value based on its Price-To-Earnings Ratio (17.4x) compared to the Global Health Care REITs industry average (26.5x).


Price to Earnings Ratio vs Fair Ratio

What is LTC's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

LTC PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio17.4x
Fair PE Ratio29.8x

Price-To-Earnings vs Fair Ratio: LTC is good value based on its Price-To-Earnings Ratio (17.4x) compared to the estimated Fair Price-To-Earnings Ratio (29.8x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst LTC forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentUS$38.70
US$37.83
-2.2%
8.4%US$42.00US$34.00n/a6
Nov ’25US$37.30
US$35.83
-3.9%
6.7%US$40.00US$33.00n/a6
Oct ’25US$36.57
US$35.50
-2.9%
8.1%US$40.00US$31.00n/a6
Sep ’25US$36.73
US$35.33
-3.8%
7.9%US$40.00US$31.00n/a6
Aug ’25US$35.75
US$35.00
-2.1%
8.7%US$41.00US$31.00n/a6
Jul ’25US$34.44
US$35.00
+1.6%
8.7%US$41.00US$31.00n/a6
Jun ’25US$34.40
US$35.00
+1.7%
8.7%US$41.00US$31.00n/a6
May ’25US$33.50
US$33.67
+0.5%
5.0%US$36.00US$31.00n/a6
Apr ’25US$32.32
US$33.67
+4.2%
5.0%US$36.00US$31.00n/a6
Mar ’25US$31.46
US$33.86
+7.6%
5.1%US$36.00US$31.00n/a7
Feb ’25US$31.47
US$34.00
+8.0%
5.7%US$37.00US$31.00n/a7
Jan ’25US$32.12
US$33.83
+5.3%
5.5%US$36.00US$31.00n/a6
Dec ’24US$33.15
US$34.00
+2.6%
6.3%US$36.00US$30.00n/a7
Nov ’24US$31.72
US$33.71
+6.3%
7.2%US$36.00US$29.00US$37.307
Oct ’24US$32.13
US$33.71
+4.9%
6.9%US$36.00US$29.00US$36.577
Sep ’24US$32.88
US$34.20
+4.0%
3.9%US$36.00US$32.00US$36.735
Aug ’24US$33.64
US$34.20
+1.7%
3.9%US$36.00US$32.00US$35.755
Jul ’24US$33.02
US$34.20
+3.6%
3.9%US$36.00US$32.00US$34.445
Jun ’24US$32.29
US$34.17
+5.8%
4.9%US$36.00US$32.00US$34.406
May ’24US$33.41
US$35.33
+5.8%
4.5%US$37.00US$32.00US$33.506
Apr ’24US$35.13
US$38.00
+8.2%
4.8%US$40.00US$35.00US$32.326
Mar ’24US$35.04
US$38.00
+8.4%
4.8%US$40.00US$35.00US$31.466
Feb ’24US$38.33
US$38.88
+1.4%
6.1%US$42.00US$35.00US$31.478
Jan ’24US$35.53
US$39.50
+11.2%
5.7%US$42.00US$35.00US$32.128
Dec ’23US$39.04
US$40.25
+3.1%
8.8%US$48.00US$35.00US$33.158
Nov ’23US$38.23
US$41.13
+7.6%
9.5%US$48.00US$35.00US$31.728

Analyst Forecast: Target price is lower than the current share price.


Discover undervalued companies